Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

BACKGROUND: Despite the high prevalence of lung cancer, with a five-year survival rate of only 23%, the underlying molecular mechanisms of non-small cell lung cancer (NSCLC) remain unknown. There is a great need to identify reliable candidate biomarker genes for early diagnosis and targeted therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Altaf, Reem, Ilyas, Umair, Ma, Anmei, Shi, Meiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264625/
https://www.ncbi.nlm.nih.gov/pubmed/37324026
http://dx.doi.org/10.3389/fonc.2023.1206768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264625/
https://www.ncbi.nlm.nih.gov/pubmed/37324026
http://dx.doi.org/10.3389/fonc.2023.1206768

Ejemplares similares